QOF database

Home | News | Downloads
UK

UK

All of the UK See member list for this organisation

CKD 5

The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)

IndicatorYearNumeratorDenominatorRatioCentile
CKD 4 2007 775789 918957 84.4%
CKD 4 2008 1003111 1194514 84.0%
CKD 5 2009 190141 217059 87.6%
CKD 5 2010 100268 109349 91.7%
CKD 5 2011 112472 124551 90.3%
CKD 5 2012 127712 142824 89.4%
CKD 5 2013 135662 152045 89.2%
CKD003NI 2014 137338 151066 90.9%
CKD003 2015 129533 141708 91.4%
CKD003 2016 107036 140482 76.2%
CKD003 2017 86743 119235 72.7%
CKD003 2018 85768 120315 71.3%
CKD003 2019 64733 94949 68.2%
CKD003 2020 76283 113079 67.5%
CKD003 2022 73365 107426 68.3%
CKD003 2023 52133 73598 70.8%